CN101472928A - 多晶形式及制备方法 - Google Patents
多晶形式及制备方法 Download PDFInfo
- Publication number
- CN101472928A CN101472928A CNA2007800223205A CN200780022320A CN101472928A CN 101472928 A CN101472928 A CN 101472928A CN A2007800223205 A CNA2007800223205 A CN A2007800223205A CN 200780022320 A CN200780022320 A CN 200780022320A CN 101472928 A CN101472928 A CN 101472928A
- Authority
- CN
- China
- Prior art keywords
- heteroaryl
- aryl
- formula
- phenyl
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06012525.9 | 2006-06-19 | ||
| EP06012525 | 2006-06-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101472928A true CN101472928A (zh) | 2009-07-01 |
Family
ID=38687475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2007800223205A Pending CN101472928A (zh) | 2006-06-19 | 2007-05-26 | 多晶形式及制备方法 |
Country Status (19)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005027170A1 (de) * | 2005-06-13 | 2006-12-14 | Merck Patent Gmbh | Substituierte Tetrahydrochinoline |
| DE102007021862A1 (de) * | 2007-05-10 | 2008-11-13 | Merck Patent Gmbh | Wässrige pharmazeutische Zubereitung |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3345355A1 (de) * | 1983-12-15 | 1985-06-27 | Hoechst Ag, 6230 Frankfurt | Verfahren zur racematspaltung bicyclischer imino-(alpha)-carbonsaeureester |
| DE4203547A1 (de) * | 1992-02-07 | 1993-08-12 | Knoll Ag | Verfahren zur racemattrennung von verapamil |
| JPH07247286A (ja) * | 1994-01-18 | 1995-09-26 | Sankyo Co Ltd | 含窒素環状化合物の光学分割方法 |
| JPH07330732A (ja) * | 1994-06-10 | 1995-12-19 | Kyorin Pharmaceut Co Ltd | 光学活性な3−アミノ−1−ベンジルピペリジン誘導体 |
| GB0010437D0 (en) * | 2000-04-28 | 2000-06-14 | Darwin Discovery Ltd | Process |
| US20040002615A1 (en) * | 2002-06-28 | 2004-01-01 | Allen David Robert | Preparation of chiral amino-nitriles |
| DK1761515T3 (da) * | 2003-12-20 | 2009-02-16 | Merck Patent Gmbh | 2-(hetero-)aryl-substituerede tetrahydroquinolinderivater |
-
2007
- 2007-05-26 KR KR1020097000904A patent/KR20090020702A/ko not_active Withdrawn
- 2007-05-26 US US12/305,524 patent/US8198452B2/en not_active Expired - Fee Related
- 2007-05-26 EP EP07725607.1A patent/EP2032581B1/en not_active Not-in-force
- 2007-05-26 EA EA200802400A patent/EA015994B1/ru not_active IP Right Cessation
- 2007-05-26 AU AU2007263393A patent/AU2007263393B2/en not_active Ceased
- 2007-05-26 JP JP2009515726A patent/JP5322928B2/ja not_active Expired - Fee Related
- 2007-05-26 NZ NZ574236A patent/NZ574236A/en not_active IP Right Cessation
- 2007-05-26 MX MX2008016071A patent/MX2008016071A/es not_active Application Discontinuation
- 2007-05-26 WO PCT/EP2007/004711 patent/WO2007147480A2/en not_active Ceased
- 2007-05-26 CA CA2656064A patent/CA2656064C/en not_active Expired - Fee Related
- 2007-05-26 CN CNA2007800223205A patent/CN101472928A/zh active Pending
- 2007-05-26 BR BRPI0712393-0A patent/BRPI0712393A2/pt not_active IP Right Cessation
- 2007-05-26 ES ES07725607.1T patent/ES2537759T3/es active Active
- 2007-06-15 PE PE2007000758A patent/PE20080337A1/es not_active Application Discontinuation
- 2007-06-15 AR ARP070102629A patent/AR061379A1/es unknown
- 2007-06-15 TW TW096121905A patent/TW200815453A/zh unknown
-
2008
- 2008-12-10 IL IL195844A patent/IL195844A0/en unknown
-
2009
- 2009-01-16 ZA ZA200900383A patent/ZA200900383B/xx unknown
- 2009-01-16 EC EC2009009077A patent/ECSP099077A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007147480A3 (en) | 2008-05-08 |
| AR061379A1 (es) | 2008-08-20 |
| EP2032581A2 (en) | 2009-03-11 |
| PE20080337A1 (es) | 2008-04-25 |
| WO2007147480A2 (en) | 2007-12-27 |
| JP2009541231A (ja) | 2009-11-26 |
| AU2007263393B2 (en) | 2012-03-01 |
| EA200802400A1 (ru) | 2009-06-30 |
| ZA200900383B (en) | 2010-01-27 |
| KR20090020702A (ko) | 2009-02-26 |
| BRPI0712393A2 (pt) | 2012-10-16 |
| NZ574236A (en) | 2010-11-26 |
| TW200815453A (en) | 2008-04-01 |
| US20090176820A1 (en) | 2009-07-09 |
| EA015994B1 (ru) | 2012-01-30 |
| ES2537759T3 (es) | 2015-06-11 |
| CA2656064C (en) | 2013-11-05 |
| JP5322928B2 (ja) | 2013-10-23 |
| MX2008016071A (es) | 2009-01-15 |
| CA2656064A1 (en) | 2007-12-27 |
| ECSP099077A (es) | 2009-02-27 |
| EP2032581B1 (en) | 2015-03-11 |
| US8198452B2 (en) | 2012-06-12 |
| IL195844A0 (en) | 2009-09-01 |
| AU2007263393A1 (en) | 2007-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112300153B (zh) | 一种杂环化合物、药物组合物和用途 | |
| CN113683614B (zh) | 用于治疗正粘病毒感染的稠合三环哒嗪酮化合物 | |
| US9440981B2 (en) | Pyrrolo[2, 1-F] [1,2,4]triazine derivative and use thereof for treating tumors | |
| TW201738236A (zh) | 一種製備酪胺酸激酶抑制劑及其衍生物的方法 | |
| CN116964044B (zh) | 乙酰胺基-苯基四唑衍生物及其使用方法 | |
| CN114685520B (zh) | 三并环化合物及其药物组合物和应用 | |
| US8198452B2 (en) | Polymorphic forms and process | |
| WO2018028491A1 (zh) | 吲哚胺2,3-双加氧酶抑制剂及其在药学中的用途 | |
| CN101265274B (zh) | 嘧啶噻唑胺衍生物、及其制法和药物组合物与用途 | |
| EA027968B1 (ru) | Гетероциклические карбоксамиды в качестве модуляторов активности киназ | |
| EP1212321B1 (en) | Intermediates for the production of naphthyridine-3-carboxylic acid derivatives | |
| JP2022503943A (ja) | Flt3およびaxlの阻害剤としての3,9-ジアザスピロ[5,5]ウンデカン系化合物 | |
| JP2015531382A (ja) | ピロリジン | |
| HK1135380A (en) | Polymorphic forms and process | |
| BRPI0611613A2 (pt) | tetraidroquinolinas substituìdas | |
| JP5236743B2 (ja) | テトラヒドロキノリン誘導体の調製方法 | |
| JP3837090B2 (ja) | 新規なインデノインドロン化合物、それらの調製方法及びそれらを含有する医薬組成物 | |
| CN119080738A (zh) | 一种含肟结构的gspt1蛋白降解剂及其制备方法和应用 | |
| CN119330953A (zh) | 雄激素受体调节剂的偶联物及其制备方法 | |
| WO2019141095A1 (zh) | 脒类和胍类衍生物、其制备方法及其在医药上的应用 | |
| HK1117829A (en) | Indole derivatives having antitumor activity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1135380 Country of ref document: HK |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20090701 |
|
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1135380 Country of ref document: HK |